Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02573779 · ClinicalTrials.gov registry record
Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk
A clinical trial, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- 125
- Enrollment target
NCT02573779: Completed study, sponsored by Baylor College of Medicine.
NCT02573779 is a clinical trial that has completed, run by Baylor College of Medicine. The registered enrollment target is 125 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02573779 has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- 125 participants
- Enrollment target
Study Summary
A study to compare growth, development of the intestinal bacterial environment, and other short term outcomes in groups of babies fed primarily their own mother's milk compared to those who receive primarily donor human milk. The investigators hypothesize that infants who receive primarily their own mother's milk will have better growth, a more diverse intestinal bacterial environment, and possibly some improved short term outcomes such as better feeding tolerance and lower rates of infection.
Primary Outcome
Stool samples during the first 6 weeks of life will be analyzed to compare development of microbial diversity
Interventions
- OTHER Observational - no intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 125 participants |
| Start Date | 2015-07-10 |
| Est. Completion | 2018-10-25 |
What the finished NCT02573779 record still lists
NCT02573779 is an observational study that tracks outcomes without assigning an intervention. The registered 125 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Observational - no intervention is the first listed.
NCT02573779 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02573779 about?
NCT02573779 is a clinical study titled "Growth and Microbiome Development in Very Low Birth Weight Infants Fed Primarily Mother's Own Milk vs. Donor Human Milk". A study to compare growth, development of the intestinal bacterial environment, and other short term outcomes in groups of babies fed primarily their own mother's milk compared to those who receive primarily donor human milk. The investigators hypothesize that infants who receive primarily their own...
What is the current status of trial NCT02573779?
This trial is currently completed. The enrollment target is 125 participants. The study started on 2015-07-10. Estimated completion is 2018-10-25.
What interventions are being tested in trial NCT02573779?
The interventions under investigation include: Observational - no intervention (OTHER).
Who is sponsoring clinical trial NCT02573779?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02717039 · 125 participants
Pharmacogenomics of Heparin-Induced Thrombocytopenia
- NCT02763033 · 125 participants · Phase 2
Dietary Manipulation of the Microbiome-metabolomic Axis for Mitigating GVHD in Allo HCT Patients
- NCT02793999 · 125 participants
Perinatal Brain Injury: Potential of Innovative NIRS to Optimize Hypothermia
- NCT03003299 · 125 participants · NA
PARTNER 3 Trial - Aortic Valve-in-Valve
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI